Zhang H - Search Results

1

Large-scale profiling of metabolic dysregulation in ovarian cancer.

Ke C, Hou Y, Zhang H, Fan L, Ge T, Guo B, Zhang F, Yang K, Wang J, Lou G, Li K. Ke C, et al. Among authors: zhang f, zhang h. Int J Cancer. 2015 Feb 1;136(3):516-26. doi: 10.1002/ijc.29010. Epub 2014 Jun 17. Int J Cancer. 2015. PMID: 24895217

2

LAPTM4B overexpression is a novel predictor of epithelial ovarian carcinoma metastasis.

Yin M, Xu Y, Lou G, Hou Y, Meng F, Zhang H, Li C, Zhou R. Yin M, et al. Among authors: zhang h. Int J Cancer. 2011 Aug 1;129(3):629-35. doi: 10.1002/ijc.25689. Epub 2010 Nov 28. Int J Cancer. 2011. PMID: 20857494

3

The long-term efficacy of neoadjuvant chemotherapy followed by radical hysterectomy compared with radical surgery alone or concurrent chemoradiotherapy on locally advanced-stage cervical cancer.

Yin M, Zhao F, Lou G, Zhang H, Sun M, Li C, Hou Y, Li X, Meng F, Chen X. Yin M, et al. Among authors: zhang h. Int J Gynecol Cancer. 2011 Jan;21(1):92-9. doi: 10.1111/IGC.0b013e3181fe8b6e. Int J Gynecol Cancer. 2011. PMID: 21330834

4

Over-expression of LAPTM4B is associated with poor prognosis and chemotherapy resistance in stages III and IV epithelial ovarian cancer.

Yin M, Li C, Li X, Lou G, Miao B, Liu X, Meng F, Zhang H, Chen X, Sun M, Ling Q, Zhou R. Yin M, et al. Among authors: zhang h. J Surg Oncol. 2011 Jul 1;104(1):29-36. doi: 10.1002/jso.21912. Epub 2011 Mar 17. J Surg Oncol. 2011. PMID: 21416470

5

The toxicity and long-term efficacy of nedaplatin and paclitaxel treatment as neoadjuvant chemotherapy for locally advanced cervical cancer.

Yin M, Zhang H, Li H, Li X, Liu Y, Chen X, Lou G, Li K. Yin M, et al. Among authors: zhang h. J Surg Oncol. 2012 Feb;105(2):206-11. doi: 10.1002/jso.22052. Epub 2011 Aug 3. J Surg Oncol. 2012. PMID: 21815150

6

LAPTM4B overexpression is a novel independent prognostic marker for metastatic ovarian tumors.

Yin M, Lou C, Zhang W, Meng F, Zhang H, Ning X, Zhou R, Dong X, Lou G. Yin M, et al. Among authors: zhang w, zhang h. Int J Gynecol Cancer. 2012 Jan;22(1):54-62. doi: 10.1097/IGC.0b013e318234f9ac. Int J Gynecol Cancer. 2012. PMID: 22193644

7

Identification of metabolic biomarkers to diagnose epithelial ovarian cancer using a UPLC/QTOF/MS platform.

Fan L, Zhang W, Yin M, Zhang T, Wu X, Zhang H, Sun M, Li Z, Hou Y, Zhou X, Lou G, Li K. Fan L, et al. Among authors: zhang w, zhang t, zhang h. Acta Oncol. 2012 Apr;51(4):473-9. doi: 10.3109/0284186X.2011.648338. Epub 2012 Jan 27. Acta Oncol. 2012. PMID: 22283470

8

Discrimination between malignant and benign ovarian tumors by plasma metabolomic profiling using ultra performance liquid chromatography/mass spectrometry.

Zhang T, Wu X, Yin M, Fan L, Zhang H, Zhao F, Zhang W, Ke C, Zhang G, Hou Y, Zhou X, Lou G, Li K. Zhang T, et al. Among authors: zhang w, zhang g, zhang h. Clin Chim Acta. 2012 May 18;413(9-10):861-8. doi: 10.1016/j.cca.2012.01.026. Epub 2012 Jan 30. Clin Chim Acta. 2012. PMID: 22309680

9

Identification of potential biomarkers for ovarian cancer by urinary metabolomic profiling.

Zhang T, Wu X, Ke C, Yin M, Li Z, Fan L, Zhang W, Zhang H, Zhao F, Zhou X, Lou G, Li K. Zhang T, et al. Among authors: zhang w, zhang h. J Proteome Res. 2013 Jan 4;12(1):505-12. doi: 10.1021/pr3009572. Epub 2012 Dec 3. J Proteome Res. 2013. PMID: 23163809

10

Prediction of advanced ovarian cancer recurrence by plasma metabolic profiling.

Zhang H, Ge T, Cui X, Hou Y, Ke C, Yang M, Yang K, Wang J, Guo B, Zhang F, Lou G, Li K. Zhang H, et al. Among authors: zhang f. Mol Biosyst. 2015 Feb;11(2):516-21. doi: 10.1039/c4mb00407h. Epub 2014 Nov 26. Mol Biosyst. 2015. PMID: 25424060

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

126,943 results

Search Page

Filters